Efficacy and Safety of Lapatinib Treatment in Trastuzumab Pretreated Patients with HER2 Positive Metastatic Breast Cancer - An Analysis of IntERB Registry in the Czech Republic

被引：0
|
作者：
Grell, P. [1 ]
Kandrnal, V. [2 ]
Bortlicek, Z. [2 ]
Vyzula, R. [1 ]
机构：
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
[2] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S94 / S95
页数：2
相关论文
共 50 条
  • [1] Lapatinib efficacy according to metastatic sites in trastuzumab pretreated patients with HER2-positive metastatic breast cancer: An analysis form IntERB registry in the Czech Republic.
    Grell, Peter
    Kandrnal, Vit
    Zbynek, Bortlicek
    Vyzula, Rostislav
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] EFFECTS OF TRASTUZUMAB AND LAPATINIB ON HER2 POSITIVE BREAST CANCER TREATMENT
    Jia, W.
    Wang, T. Z.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (02): : 551 - 555
  • [3] Tolerability of the combination of lapatinib and trastuzumab in older patients with HER2 positive metastatic breast cancer
    O'Connor, Tracey
    Soto-Perez-de-Celis, Enrique
    Blanchard, Suzette
    Chapman, Andrew
    Kimmick, Gretchen
    Muss, Hyman
    Luu, Thehang
    Waisman, James R.
    Li, Daneng
    Mortimer, Joanne
    Yuan, Yuan
    Somlo, George
    Stewart, Daphne
    Katheria, Vani
    Levi, Abrahm
    Hurria, Arti
    CANCER RESEARCH, 2018, 78 (04)
  • [4] EGFR Gene Copy Number and Response to Lapatinib/Capecitabine in HER2 Positive Metastatic Breast Cancer Patients Pretreated with Trastuzumab.
    Fabi, A.
    Giaziano, V
    Merola, R.
    Metro, G.
    Papaldo, P.
    Cianciulli, A. M.
    Mottolese, M.
    Sperduti, I
    Vico, E.
    Cognetti, F.
    CANCER RESEARCH, 2009, 69 (24) : 677S - 678S
  • [5] Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer
    Osako, Tomo
    Ito, Yoshinori
    Takahashi, Shunji
    Tokudome, Nahomi
    Iwase, Takuji
    Hatake, Kiyohiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 159 - 164
  • [6] Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer
    Tomo Osako
    Yoshinori Ito
    Shunji Takahashi
    Nahomi Tokudome
    Takuji Iwase
    Kiyohiko Hatake
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 159 - 164
  • [7] Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
    Bahceci, Aykut
    Paydas, Semra
    Ak, Naziye
    Ferhatoglu, Ferhat
    Saip, Pinar Mualla
    Seydaoglu, Gulsah
    Bilici, Mehmet
    Simsek, Melih
    Tekin, Salim Basol
    Calikusu, Zuleyha
    Yavuz, Sinan
    Sahin, Ahmet Bilgehan
    Cubukcu, Erdem
    Evrensel, Turkkan
    Degirmencioglu, Serkan
    Demiray, Atike Gokcen
    Yumuk, Perran Fulden
    Alan, Ozkan
    Cikman, Duygu Ilke
    Demirelli, Fuat Hulusi
    Kostek, Osman
    Gokyer, Ali
    Dogan, Mutlu
    Bal, Oznur
    Cakar, Burcu
    Gokmen, Erhan
    Yamac, Deniz
    Korkmaz, Taner
    Aliyev, Altay
    Keskin, Ozge
    Urvay, Semiha
    Buyuksimsek, Mahmut
    Karadeniz, Cemile
    Yildiz, Birol
    Cinkir, Havva Yesil
    Demir, Hacer
    Beypinar, Ismail
    Karacin, Cengiz
    Eser, Kadir
    Baykara, Meltem
    Kilickap, Saadettin
    Okutur, Kerem
    Bulut, Gulcan
    Alkan, Ali
    Arpaci, Erkan
    Pilanci, Kezban Nur
    Demir, Atakan
    Isik, Deniz
    Yildirim, Nilgun
    CANCER INVESTIGATION, 2021, 39 (6-7) : 473 - 481
  • [8] LAPATINIB IN HER2 POSITIVE METASTATIC CARCINOMA BREAST
    Behera, M. K.
    Sharma, A.
    Shukla, P.
    Julka, P. K.
    Rath, G. K.
    ANNALS OF ONCOLOGY, 2012, 23 : 50 - 50
  • [9] HER2 suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (LPT112515).
    Lin, N. U.
    Danso, M. A.
    David, A. K.
    Muscato, J. J.
    Ellis, C. E.
    Lahiri, S.
    Sessa, T.
    Nagarwala, Y. M.
    Winer, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Trastuzumab and Gemcitabine in Pretreated HER2 Overexpressing Metastatic Breast Cancer Patients: Retrospective Analysis of Our Series
    Di Lauro, Vincenzo
    Torrisi, Elena
    Bidoli, Ettore
    Quitadamo, Daniela
    Cecco, Sara
    Veronesi, Andrea
    JOURNAL OF ONCOLOGY, 2012, 2012
12345